HUAWEI Watch D Series in the Context of New Business and Revenue Models in the MedTech Industry
摘要
By 2024, Huawei had become the world’s leading wearables company, driven by its focus on health-oriented innovation. The HUAWEI Watch D, launched in 2022, introduced medically certified blood pressure and ECG monitoring in a compact, easy-to-use smartwatch. Its oscillometric measurement system with a built-in inflatable cuff provided more accurate readings than optical-only competitors. With a strong focus on design, comfort and sensor integration, Huawei made the device practical for everyday use. The Watch D received medical certification under both the EU’s MDR and China’s NMPA, enhancing its credibility and appeal to healthcare professionals. Over one million units were sold worldwide, with significant uptake in Europe. Huawei’s successor, the Watch D2, enabled remote consultations and wider clinical integration. This case illustrates how wearables can bridge the gap between consumer electronics and regulated medical devices through innovation and strategic certification.